As at April 2017, Cancer52 has published a review of the progress of the recommendations contained in ‘Achieving World Class Cancer Outcomes:  A Strategy for England 2015-2020’ in its Cancer Strategy recommendations grid April .

On 28th July 2016 Cancer52 published its Cancer52 Position Paper on the new Cancer Drugs Fund Operating Model FINAL 28th July 2016.

On 22nd June 2016 Cancer52 published its Cancer52 position statement Cancer Implementation Plan June 2016 FINAL.

On 23rd December 2015, Cancer52 published its Briefing Paper on Access to Medicines and Treatments.

On 5th June 2014, Cancer52 published its Briefing Paper on Access to Orphan Medicines in the UK.

On 24th February 2014, Cancer52 published its Briefing Paper on the UK Strategy for Rare Diseases.

On 21st February 2014, Cancer52 published its Briefing Paper "VBA: NICE do it their way".

On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an introductory debate on the topic among leading experts from within the Cancer52 family.